The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 21, 2021
Filed:
May. 26, 2020
Applicant:
Syneurx International (Taiwan) Corp., New Taipei, TW;
Inventors:
Guochuan Emil Tsai, Pasadena, CA (US);
Ching-Cheng Wang, New Taipei, TW;
Tien-Lan Hsieh, New Taipei, TW;
Yi-Wen Mao, New Taipei, TW;
Assignee:
SYNEURX INTERNATIONAL (TAIWAN) CORP., New Taipei, TW;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7024 (2006.01); A23L 33/105 (2016.01); A23L 33/10 (2016.01); A23L 33/00 (2016.01); A61P 5/50 (2006.01); A61P 25/28 (2006.01); A61P 25/30 (2006.01); A61P 1/16 (2006.01); A61P 9/00 (2006.01); A61P 11/06 (2006.01); C07H 1/08 (2006.01); C07H 13/08 (2006.01); A61K 36/82 (2006.01); A61K 36/87 (2006.01); A61K 38/26 (2006.01); A61K 45/06 (2006.01); A61K 36/185 (2006.01); A61K 36/22 (2006.01); A61K 36/48 (2006.01); A61K 36/49 (2006.01); A61P 25/18 (2006.01); A61P 25/24 (2006.01); A61P 11/00 (2006.01); A61P 25/16 (2006.01); A61K 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7024 (2013.01); A23L 33/10 (2016.08); A23L 33/105 (2016.08); A23L 33/30 (2016.08); A61K 31/00 (2013.01); A61K 36/185 (2013.01); A61K 36/22 (2013.01); A61K 36/48 (2013.01); A61K 36/49 (2013.01); A61K 36/82 (2013.01); A61K 36/87 (2013.01); A61K 38/26 (2013.01); A61K 45/06 (2013.01); A61P 1/16 (2018.01); A61P 5/50 (2018.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 11/06 (2018.01); A61P 25/16 (2018.01); A61P 25/18 (2018.01); A61P 25/24 (2018.01); A61P 25/28 (2018.01); A61P 25/30 (2018.01); C07H 1/08 (2013.01); C07H 13/08 (2013.01); A23V 2002/00 (2013.01); Y02A 50/30 (2018.01);
Abstract
Compositions (e.g., pharmaceutical compositions, nutraceutical compositions or medical food compositions) comprising tannic acids, particularly tannic acids which are D-amino acid oxidase inhibitor with superior potency, purity and safety profile; and uses thereof for treating CNS disorder and obesity disorders including diabetes, hyperglycemia, hyperlipidemia or hypercholesterolemia.